![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7461420 / 38656-39463
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T203","span":{"begin":467,"end":474},"obj":"Body_part"}],"attributes":[{"id":"A203","pred":"fma_id","subj":"T203","obj":"http://purl.org/sig/ont/fma/fma82757"}],"text":"The disclosure of the first crystal structure of the SARS‐CoV‐1 Mpro in complex with a peptidic inhibitor Cbz‐Val‐Asn‐Ser‐Thr‐Leu‐Gln‐chloromethyl ketone (also known as hexapeptide chloromethyl ketone; 28) 125 provided clues for the substrate‐based design. Although it is a substrate analog for the porcine transmissible gastroenteritis CoV (TGEV) Mpro, it offers a structural explanation for the P1‐Gln entering into the specific subsite S1 pocket and decreased P2‐leucine specificity in the hydrophobic S2 site of SARS‐CoV‐1 Mpro. Additionally, rupintrivir (29; AG7088), a peptidomimetic inhibitor of human rhinovirus 3C protease is oriented similar to inhibitor 28 in the binding pocket of TGEV Mpro. 129 These two molecules became prototype compounds for the development of SARS‐CoV‐1 Mpro inhibitors."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T210","span":{"begin":53,"end":57},"obj":"Disease"},{"id":"T211","span":{"begin":300,"end":337},"obj":"Disease"},{"id":"T212","span":{"begin":322,"end":337},"obj":"Disease"},{"id":"T213","span":{"begin":517,"end":521},"obj":"Disease"},{"id":"T214","span":{"begin":780,"end":784},"obj":"Disease"}],"attributes":[{"id":"A210","pred":"mondo_id","subj":"T210","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A211","pred":"mondo_id","subj":"T211","obj":"http://purl.obolibrary.org/obo/MONDO_0025420"},{"id":"A212","pred":"mondo_id","subj":"T212","obj":"http://purl.obolibrary.org/obo/MONDO_0002269"},{"id":"A213","pred":"mondo_id","subj":"T213","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A214","pred":"mondo_id","subj":"T214","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The disclosure of the first crystal structure of the SARS‐CoV‐1 Mpro in complex with a peptidic inhibitor Cbz‐Val‐Asn‐Ser‐Thr‐Leu‐Gln‐chloromethyl ketone (also known as hexapeptide chloromethyl ketone; 28) 125 provided clues for the substrate‐based design. Although it is a substrate analog for the porcine transmissible gastroenteritis CoV (TGEV) Mpro, it offers a structural explanation for the P1‐Gln entering into the specific subsite S1 pocket and decreased P2‐leucine specificity in the hydrophobic S2 site of SARS‐CoV‐1 Mpro. Additionally, rupintrivir (29; AG7088), a peptidomimetic inhibitor of human rhinovirus 3C protease is oriented similar to inhibitor 28 in the binding pocket of TGEV Mpro. 129 These two molecules became prototype compounds for the development of SARS‐CoV‐1 Mpro inhibitors."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T452","span":{"begin":85,"end":86},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T453","span":{"begin":87,"end":95},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T454","span":{"begin":110,"end":113},"obj":"http://purl.obolibrary.org/obo/CLO_0037067"},{"id":"T455","span":{"begin":273,"end":274},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T456","span":{"begin":365,"end":366},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T457","span":{"begin":398,"end":400},"obj":"http://purl.obolibrary.org/obo/CLO_0008285"},{"id":"T458","span":{"begin":440,"end":442},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T459","span":{"begin":464,"end":466},"obj":"http://purl.obolibrary.org/obo/CLO_0008307"},{"id":"T460","span":{"begin":506,"end":508},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T461","span":{"begin":506,"end":508},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T462","span":{"begin":574,"end":575},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T463","span":{"begin":604,"end":609},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"The disclosure of the first crystal structure of the SARS‐CoV‐1 Mpro in complex with a peptidic inhibitor Cbz‐Val‐Asn‐Ser‐Thr‐Leu‐Gln‐chloromethyl ketone (also known as hexapeptide chloromethyl ketone; 28) 125 provided clues for the substrate‐based design. Although it is a substrate analog for the porcine transmissible gastroenteritis CoV (TGEV) Mpro, it offers a structural explanation for the P1‐Gln entering into the specific subsite S1 pocket and decreased P2‐leucine specificity in the hydrophobic S2 site of SARS‐CoV‐1 Mpro. Additionally, rupintrivir (29; AG7088), a peptidomimetic inhibitor of human rhinovirus 3C protease is oriented similar to inhibitor 28 in the binding pocket of TGEV Mpro. 129 These two molecules became prototype compounds for the development of SARS‐CoV‐1 Mpro inhibitors."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T356","span":{"begin":96,"end":105},"obj":"Chemical"},{"id":"T357","span":{"begin":106,"end":109},"obj":"Chemical"},{"id":"T358","span":{"begin":110,"end":113},"obj":"Chemical"},{"id":"T360","span":{"begin":114,"end":117},"obj":"Chemical"},{"id":"T363","span":{"begin":118,"end":121},"obj":"Chemical"},{"id":"T365","span":{"begin":122,"end":125},"obj":"Chemical"},{"id":"T367","span":{"begin":126,"end":129},"obj":"Chemical"},{"id":"T370","span":{"begin":130,"end":133},"obj":"Chemical"},{"id":"T371","span":{"begin":147,"end":153},"obj":"Chemical"},{"id":"T372","span":{"begin":194,"end":200},"obj":"Chemical"},{"id":"T373","span":{"begin":398,"end":400},"obj":"Chemical"},{"id":"T374","span":{"begin":401,"end":404},"obj":"Chemical"},{"id":"T375","span":{"begin":464,"end":466},"obj":"Chemical"},{"id":"T376","span":{"begin":467,"end":474},"obj":"Chemical"},{"id":"T377","span":{"begin":506,"end":508},"obj":"Chemical"},{"id":"T378","span":{"begin":576,"end":590},"obj":"Chemical"},{"id":"T379","span":{"begin":591,"end":600},"obj":"Chemical"},{"id":"T380","span":{"begin":656,"end":665},"obj":"Chemical"},{"id":"T381","span":{"begin":720,"end":729},"obj":"Chemical"},{"id":"T382","span":{"begin":791,"end":806},"obj":"Chemical"},{"id":"T383","span":{"begin":796,"end":806},"obj":"Chemical"}],"attributes":[{"id":"A356","pred":"chebi_id","subj":"T356","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A357","pred":"chebi_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/CHEBI_51097"},{"id":"A358","pred":"chebi_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/CHEBI_16414"},{"id":"A359","pred":"chebi_id","subj":"T358","obj":"http://purl.obolibrary.org/obo/CHEBI_30015"},{"id":"A360","pred":"chebi_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/CHEBI_17196"},{"id":"A361","pred":"chebi_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/CHEBI_22653"},{"id":"A362","pred":"chebi_id","subj":"T360","obj":"http://purl.obolibrary.org/obo/CHEBI_50347"},{"id":"A363","pred":"chebi_id","subj":"T363","obj":"http://purl.obolibrary.org/obo/CHEBI_17115"},{"id":"A364","pred":"chebi_id","subj":"T363","obj":"http://purl.obolibrary.org/obo/CHEBI_29999"},{"id":"A365","pred":"chebi_id","subj":"T365","obj":"http://purl.obolibrary.org/obo/CHEBI_16857"},{"id":"A366","pred":"chebi_id","subj":"T365","obj":"http://purl.obolibrary.org/obo/CHEBI_30013"},{"id":"A367","pred":"chebi_id","subj":"T367","obj":"http://purl.obolibrary.org/obo/CHEBI_15603"},{"id":"A368","pred":"chebi_id","subj":"T367","obj":"http://purl.obolibrary.org/obo/CHEBI_25017"},{"id":"A369","pred":"chebi_id","subj":"T367","obj":"http://purl.obolibrary.org/obo/CHEBI_30006"},{"id":"A370","pred":"chebi_id","subj":"T370","obj":"http://purl.obolibrary.org/obo/CHEBI_30011"},{"id":"A371","pred":"chebi_id","subj":"T371","obj":"http://purl.obolibrary.org/obo/CHEBI_17087"},{"id":"A372","pred":"chebi_id","subj":"T372","obj":"http://purl.obolibrary.org/obo/CHEBI_17087"},{"id":"A373","pred":"chebi_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/CHEBI_60949"},{"id":"A374","pred":"chebi_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/CHEBI_30011"},{"id":"A375","pred":"chebi_id","subj":"T375","obj":"http://purl.obolibrary.org/obo/CHEBI_33472"},{"id":"A376","pred":"chebi_id","subj":"T376","obj":"http://purl.obolibrary.org/obo/CHEBI_25017"},{"id":"A377","pred":"chebi_id","subj":"T377","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A378","pred":"chebi_id","subj":"T378","obj":"http://purl.obolibrary.org/obo/CHEBI_63175"},{"id":"A379","pred":"chebi_id","subj":"T379","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A380","pred":"chebi_id","subj":"T380","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A381","pred":"chebi_id","subj":"T381","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A382","pred":"chebi_id","subj":"T382","obj":"http://purl.obolibrary.org/obo/CHEBI_147285"},{"id":"A383","pred":"chebi_id","subj":"T383","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"The disclosure of the first crystal structure of the SARS‐CoV‐1 Mpro in complex with a peptidic inhibitor Cbz‐Val‐Asn‐Ser‐Thr‐Leu‐Gln‐chloromethyl ketone (also known as hexapeptide chloromethyl ketone; 28) 125 provided clues for the substrate‐based design. Although it is a substrate analog for the porcine transmissible gastroenteritis CoV (TGEV) Mpro, it offers a structural explanation for the P1‐Gln entering into the specific subsite S1 pocket and decreased P2‐leucine specificity in the hydrophobic S2 site of SARS‐CoV‐1 Mpro. Additionally, rupintrivir (29; AG7088), a peptidomimetic inhibitor of human rhinovirus 3C protease is oriented similar to inhibitor 28 in the binding pocket of TGEV Mpro. 129 These two molecules became prototype compounds for the development of SARS‐CoV‐1 Mpro inhibitors."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1200","span":{"begin":791,"end":795},"obj":"Gene"},{"id":"1201","span":{"begin":64,"end":68},"obj":"Gene"},{"id":"1202","span":{"begin":699,"end":703},"obj":"Gene"},{"id":"1203","span":{"begin":528,"end":532},"obj":"Gene"},{"id":"1204","span":{"begin":349,"end":353},"obj":"Gene"},{"id":"1205","span":{"begin":53,"end":61},"obj":"Species"},{"id":"1206","span":{"begin":343,"end":347},"obj":"Species"},{"id":"1207","span":{"begin":517,"end":525},"obj":"Species"},{"id":"1208","span":{"begin":604,"end":622},"obj":"Species"},{"id":"1209","span":{"begin":694,"end":698},"obj":"Species"},{"id":"1210","span":{"begin":780,"end":788},"obj":"Species"},{"id":"1211","span":{"begin":308,"end":321},"obj":"Species"},{"id":"1212","span":{"begin":106,"end":153},"obj":"Chemical"},{"id":"1213","span":{"begin":181,"end":200},"obj":"Chemical"},{"id":"1214","span":{"begin":398,"end":400},"obj":"Chemical"},{"id":"1215","span":{"begin":401,"end":404},"obj":"Chemical"},{"id":"1216","span":{"begin":467,"end":474},"obj":"Chemical"},{"id":"1217","span":{"begin":548,"end":559},"obj":"Chemical"},{"id":"1218","span":{"begin":565,"end":571},"obj":"Chemical"},{"id":"1219","span":{"begin":322,"end":341},"obj":"Disease"}],"attributes":[{"id":"A1200","pred":"tao:has_database_id","subj":"1200","obj":"Gene:8673700"},{"id":"A1201","pred":"tao:has_database_id","subj":"1201","obj":"Gene:8673700"},{"id":"A1202","pred":"tao:has_database_id","subj":"1202","obj":"Gene:8673700"},{"id":"A1203","pred":"tao:has_database_id","subj":"1203","obj":"Gene:8673700"},{"id":"A1204","pred":"tao:has_database_id","subj":"1204","obj":"Gene:8673700"},{"id":"A1205","pred":"tao:has_database_id","subj":"1205","obj":"Tax:694009"},{"id":"A1206","pred":"tao:has_database_id","subj":"1206","obj":"Tax:11149"},{"id":"A1207","pred":"tao:has_database_id","subj":"1207","obj":"Tax:694009"},{"id":"A1208","pred":"tao:has_database_id","subj":"1208","obj":"Tax:44130"},{"id":"A1209","pred":"tao:has_database_id","subj":"1209","obj":"Tax:11149"},{"id":"A1210","pred":"tao:has_database_id","subj":"1210","obj":"Tax:694009"},{"id":"A1211","pred":"tao:has_database_id","subj":"1211","obj":"Tax:11149"},{"id":"A1214","pred":"tao:has_database_id","subj":"1214","obj":"MESH:C480041"},{"id":"A1215","pred":"tao:has_database_id","subj":"1215","obj":"MESH:D005973"},{"id":"A1216","pred":"tao:has_database_id","subj":"1216","obj":"MESH:D007930"},{"id":"A1217","pred":"tao:has_database_id","subj":"1217","obj":"MESH:C118874"},{"id":"A1218","pred":"tao:has_database_id","subj":"1218","obj":"MESH:C118874"},{"id":"A1219","pred":"tao:has_database_id","subj":"1219","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The disclosure of the first crystal structure of the SARS‐CoV‐1 Mpro in complex with a peptidic inhibitor Cbz‐Val‐Asn‐Ser‐Thr‐Leu‐Gln‐chloromethyl ketone (also known as hexapeptide chloromethyl ketone; 28) 125 provided clues for the substrate‐based design. Although it is a substrate analog for the porcine transmissible gastroenteritis CoV (TGEV) Mpro, it offers a structural explanation for the P1‐Gln entering into the specific subsite S1 pocket and decreased P2‐leucine specificity in the hydrophobic S2 site of SARS‐CoV‐1 Mpro. Additionally, rupintrivir (29; AG7088), a peptidomimetic inhibitor of human rhinovirus 3C protease is oriented similar to inhibitor 28 in the binding pocket of TGEV Mpro. 129 These two molecules became prototype compounds for the development of SARS‐CoV‐1 Mpro inhibitors."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T358","span":{"begin":0,"end":257},"obj":"Sentence"},{"id":"T359","span":{"begin":258,"end":533},"obj":"Sentence"},{"id":"T360","span":{"begin":534,"end":704},"obj":"Sentence"},{"id":"T361","span":{"begin":705,"end":807},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The disclosure of the first crystal structure of the SARS‐CoV‐1 Mpro in complex with a peptidic inhibitor Cbz‐Val‐Asn‐Ser‐Thr‐Leu‐Gln‐chloromethyl ketone (also known as hexapeptide chloromethyl ketone; 28) 125 provided clues for the substrate‐based design. Although it is a substrate analog for the porcine transmissible gastroenteritis CoV (TGEV) Mpro, it offers a structural explanation for the P1‐Gln entering into the specific subsite S1 pocket and decreased P2‐leucine specificity in the hydrophobic S2 site of SARS‐CoV‐1 Mpro. Additionally, rupintrivir (29; AG7088), a peptidomimetic inhibitor of human rhinovirus 3C protease is oriented similar to inhibitor 28 in the binding pocket of TGEV Mpro. 129 These two molecules became prototype compounds for the development of SARS‐CoV‐1 Mpro inhibitors."}